Franklin Genomic Advancements ETF (HELX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HELX | ||||
| Company | Franklin Genomic Advancements ETF | ||||
| Price Information | |||||
| Exchange | NYSE Arca | ||||
| Open | 36.49 | ||||
| High | 36.49 | ||||
| Low | 36.49 | ||||
| Latest | 36.49 | ||||
| Change | +0.45 | ||||
| % Change | +1.24% | ||||
| Volume | 100 | ||||
| 20-Day Average Volume | 375 | ||||
| Previous Close | 36.04 | ||||
| Industry | N/A | ||||
| Has Options | Yes | ||||
| Technicals | |||||
| 20-Day Moving Average | 35.16 | ||||
| 20-Day Raw Stochastic | 100.00% | ||||
| 20-Day Relative Strength | 60.64 | ||||
| Weighted Alpha | +30.02 | ||||
| Today's Opinion | 56% Buy | ||||
| Previous Opinion | 56% Buy | ||||
| Last Month's Opinion | 72% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.19% since 06/11/26 | ||||
| Low | 35.45 on 06/12/26 | ||||
| High | 36.49 on 06/18/26 | ||||
| 1-Month | |||||
| %Chg | +12.18% since 05/18/26 | ||||
| Low | 32.50 on 05/19/26 | ||||
| High | 36.49 on 06/18/26 | ||||
| 3-Month | |||||
| %Chg | +13.46% since 03/18/26 | ||||
| Low | 31.24 on 03/27/26 | ||||
| High | 36.49 on 06/18/26 | ||||
| 6-Month | |||||
| %Chg | +1.20% since 12/18/25 | ||||
| Low | 31.24 on 03/27/26 | ||||
| High | 38.17 on 01/07/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 23,718 | ||||
| Shares Outstanding, K | 650 | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | 0 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | 1.02 | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Earnings Date | N/A | ||||
| Most Recent Dividend | 0.143 on 12/30/25 | ||||
| Next Ex-Dividends Date | 12/30/25 | ||||
| Ratios | |||||
| Price/Earnings ttm | 29.78 | ||||